Scientific Advisory Board2018-12-18T13:48:24+00:00

Scientific Advisory Board

Kevin Schultz, DVM, PhD Immunology, Medicine, Microbiology serves as Chair of our scientific advisory board. Kevin has previously served as chief scientific officer of Kindred Biosciences, chief scientific officer and head of global R&D at Merial, and executive director of worldwide animal science research and development at Merck. Prior to that, he was a Professor of Pathobiological Sciences at the University of Wisconsin-Madison and managed his own veterinary practice. Dr. Schultz serves as an industry consultant for human and animal health research and development, and was appointed as CEO of Pathens, LLC. He is also a Venture Fellow with the George Research Alliance. Dr. Schultz is a graduate of University of Illinois (PhD), Purdue University (DVM) and completed his post doc at Harvard Medical School.

Jeffrey Bryan, DVM, MS, PhD, DACVIM-Oncology Professor, Oncology is the Director of the Comparative Oncology, Radiobiology, and Epigenetics Laboratory at the University of Missouri. The laboratory focuses on the comparative examination of cancers, from carcinogenesis mechanisms to biomarkers of disease and prognosis to novel therapy development. Dr. Bryan also leads trials in the imaging and immunotherapy of cancers, including malignant melanoma. Dr. Bryan is the Director of the new PET Imaging Center of the University of Missouri which will serve as a core center for radiotracer design and PET image generation for animals and plants. Dr. Bryan is a graduate of the University of California, Davis (BS, DVM), and the University of Missouri (MS, PhD).

Lee Herron, DVM directs the Georgia Research Alliance’s (GRA) venture development program, which has launched 180 companies and attracted more than $1 billion in equity investment. Drawing on his own 17 years of entrepreneurial experience, he ensures that companies adopt a sound business strategy and operational plans. Dr. Herron serves on the board of numerous bio and life sciences companies and numerous advisory committees, and he was chairman of the 2017 Georgia BIO Life Science Summit. Dr. Herron is a graduate of the University of Georgia (DVM).

Noe Reyes, DVM, is Chief Medical Officer and a member of our scientific advisory board. Dr. Reyes brings extensive experience as both a veterinarian and animal health researcher. He oversees the design and conduct of the company’s clinical trials and is the company’s medical liaison to veterinarians and veterinary oncologists. Previously, Dr. Reyes has served as medical director for Kindred Biosciences, a development-stage veterinary biopharmaceutical company, and in scientific positions with Achaogen and Theravance Biopharma, as well as the United States Army Veterinary Corps, where he was responsible for the medical care of military working dogs and equine at installations in California and Texas. Dr. Reyes is a graduate of the University of California, Davis (BS, DVM).

Ralph Richardson, DVM, DACVIM Internal Medicine and Oncology, is Dean and CEO of the Kansas State University-Olathe and previously served as dean of the College of Veterinary Medicine at Kansas State University from August 1998 to June 2015, and where he continues as a faculty member. Prior to that, he served as a faculty member and head of the clinical sciences department at Purdue University, served as a Captain in the U.S. Army Veterinary Corps, and was in private practice in Miami, Florida. He is Past President of the Veterinary Cancer Society, the Specialty of Oncology in the American College of Veterinary Internal Medicine, and the American Association of Veterinary Clinicians, and is actively engage in public health and comparative medicine programs. Dr. Richardson is a graduate of Kansas State University (BS, DVM) and completed his post-graduate internship at Purdue University.

Ron Schultz, PhD is a recognized leader on veterinary vaccines, virology and immunology. He currently serves as professor and chair of the Department of Pathobiological Sciences at the School of Veterinary Medicine at the University of Wisconsin-Madison. His primary emphasis of research focuses on the pathogenesis of viral infections in large and companion animals. Dr. Schultz is a graduate of Pennsylvania State University (BS, MS, PhD) and is an honorary diplomate from the American College of Veterinary Microbiology.